Renal & Urology News

Gene Signature Predicts Worse PCa Patient Survival

Researchers have identified a six-gene signature that can be used in a test to predict survival in men with aggressive prostate cancer (PCa), according to study findings published online in The Lancet ...
Renal & Urology News

Comorbidities Affect PCa Patient Death Risk

ORLANDO—Overall mortality among men with localized prostate cancer (PCa) increases with their burden of comorbid conditions, according to study findings presented at the fourth annual Genitourinary ...
ascopubs.org

Patterns of use of docetaxel in stage IV prostate cancer (PCa) patients in SEER-Medicare.

A retrospective analysis of intramural NCI prostate cancer trials: Progress made and insights gleaned. Background: To date, docetaxel (D) is the only chemotherapy agent that has provided a survival ...
Medscape

Evaluating Treatments and Corresponding Costs of Prostate Cancer Patients Treated Within an Inpatient or Hospital-based Outpatient Setting

Bayer HealthCare provided support for this research. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial ...
ascopubs.org

Tumor transcriptomic profile in patients (pts) with advanced prostate cancer (PCa) with cribriform and signet ring-like histologies.

Single and multi-hit PIK3CA short variant (SV) genomic alterations (GA) in clinically advanced prostate cancer (CAPC): A genomic landscape study. Homologous recombination repair (HRR) mutation ...